Skip to main content
. 2021 Sep 29;21:377. doi: 10.1186/s12883-021-02386-3

Table 1.

Baseline and procedure characteristics of patients with AF versus without AF

Baseline and procedure variables Pre-matched population (n = 1755) Post-matched population (n = 814)
With AF
(n = 550)
Without AF
(n = 1205)
SD (%) P-value With AF
(n = 407)
Without AF
(n = 407)
SD (%) P-value
Age, median (IQR), years 71 (64–78) 63 (54–70) 72.0 < 0.01 69 (62–76) 68 (61–75) 4.3 0.32
Male sex 246 (44.7) 910 (75.5) 66.2 < 0.01 213 (52.3) 221 (54.3) 3.9 0.57
History of hypertension 333 (60.6) 673 (55.9) 9.5 0.07 232 (57.0) 245 (60.2) 6.5 0.35
History of diabetes mellitus 99 (18.0) 225 (18.7) 1.8 0.74 73 (17.9) 82 (20. 2) 5.6 0.42
Prior ischemic stroke 130 (23.6) 207 (17.2) 16.1 < 0.01 85 (20.9) 88 (21.6) 1.8 0.80
Pre-stroke mRS score ≥ 1 84 (15.3) 146 (12.1) 9.2 0.07 55 (13.5) 60 (14.7) 3.5 0.61
Cigarette smoking 56.5 < 0.01 7.3 0.27
 Never Smoker 420 (76.4) 629 (52.2) 291 285
 Ex-smoker 44 (8.0) 89 (7.4) 37 28
 Current smoker 86 (15.6) 487 (40. 4) 79 94
Systolic blood pressure, median (IQR), mmHg 145 (130–160) 145 (132–162) 7.5 0. 21 145 (130–160) 145 (130–160) 2.1 0.95
NIHSS score, median (IQR) 18 (14–22) 15 (11–21) 29.5 < 0.01 17 (13–21) 17 (13–22) 2.6 0.87
ASPECTS, median (IQR) a 10 (7–10) 9 (7–10) 13.1 < 0.01 10 (7–10) 10 (7–10) 1.5 0.91
Occlusion site 46.4 < 0.01 9.1 0.20
 Internal carotid artery 166 (30.2) 279 (23.2) 111 (27.3) 116 (28.5)
 Middle cerebral artery M1 segment 266 (48.4) 493 (40.9) 197 (48.4) 187 (45.9)
 Middle cerebral artery M2 segment 59 (10.7) 91 (7.6) 47 (11.6) 39 (9.6)
 Vertebro-basilar artery 49 (8.9) 313 (26.0) 42 (10.3) 60 (14.7)
 Other intracranial arteries b 10 (1.8) 29 (2.4) 10 (2.5) 5 (1. 2)
Prior use of antiplatelet agents 101 (18.4) 187 (15.5) 7.8 0.14 75 (18.4) 73 (17.9) 1.3 0.86
Prior use of anticoagulants 51 (9.3) 20 (1.7) 34.0 < 0.01 19 (4. 7) 15 (3.7) 4.9 0.48
Prior intravenous thrombolysis 145 (26.4) 368 (30.5) 9.3 0.07 115 (28.3) 102 (25.1) 7.2 0.30
Type of anesthesia 16.8 0.01 4.1 0.55
 Local anesthesia only 265 (48.2) 500 (41.5) 190 (46.7) 184 (45.2)
 Local anesthesia plus sedation 92 (16.7) 190 (15.8) 68 (16.7) 60 (14.7)
 General anesthesia 193 (35.1) 515 (42.7) 149 (36.6) 163 (40.1)
Stent-retriever thrombectomy 385 (70.0) 834 (69.2) 1.7 0.74 284 (69.8) 289 (71.0) 2.7 0.70
Aspiration thrombectomy 14 (2. 6) 40 (3.3) 4.6 0.38 13 (3.2) 15 (3.7) 2.7 0.70
Stent-retriever plus aspiration thrombectomy 124 (22.6) 180 (14.9) 19.6 < 0.01 83 (20.4) 77 (18.9) 3.7 0.60
Pass number of thrombectomy, median (IQR) 2 (1–3) 1 (1, 2) 40.8 < 0.01 2 (1–3) 2 (1–3) 1.4 0.79
Emergency angioplasty/stenting 45 (8.2) 471 (39.1) 78.1 < 0.01 45 (11.1) 57 (14.0) 8.9 0.20
Intra-arterial thrombolysis 33 (6.0) 111 (9.2) 12.1 0.02 31 (7.6) 31 (7.6) 0.0 1.00
Intra-procedural use of tirofiban 201 (36.6) 712 (59.1) 46.3 < 0.01 167 (41.0) 186 (45.7) 9.3 0.18
Intra-procedural use of heparin 251 (45.6) 606 (50.3) 9.3 0.07 187 (46.0) 178 (43.7) 4.5 0.53
Onset-to-puncture time, median (IQR), min 260 (195–370) 325 (225–484) 30.8 < 0.01 284 (200–390) 290 (210–410) 6.0 0.22
Puncture-to-recanalization time, median (IQR), min 80 (50–120) 89 (54–135) 11.2 0.01 79 (50–120) 87 (53–128) 5.3 0.19

Abbreviations: AF atrial fibrillation, ASPECTS Alberta Stroke Program Early CT Score, IQR interquartile range, mRS modified Rankin Scale, NIHSS National Institutes of Health Stroke Scale, pc-ASPECTS posterior circulation Alberta Stroke Program Early CT Score, SD standardized difference

Values are numbers with percentages in parentheses, unless indicated otherwise

aASPECTS for anterior circulation stroke, and pc-ASPECTS for posterior circulation stroke

bincluding anterior cerebral artery A1/A2 segments, posterior cerebral artery P1 segment